The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Therapeutic potential of nanoparticulate systems for macrophage targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Mechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634
Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417 · cited 1×
“[144]).”
Renno, T., Krakowski, M., Piccirillo, C., Lin, J. Y., & Owens, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.944 · Cited by 401
Schäfer, V., von Briesen, H., Andreesen, R., Steffan, A.-M., Royer, C., Tröster, S., Kreuter, J., & Rübsamen-Waigmann, H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015852732512 · Cited by 146 · cited 2×
“[114] Schafer V, von Briesen H, Andreesen R, Steffan AM, Royer C,”
BackgroundMethodLöbenberg, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00105-3 · Cited by 109 · cited 2×
“Thus, increasing drug concentrations at specific sites where macrophages are abundant may allow a reduction in the dosage and, as a result, a decrease in systemic toxicity [112].”
BackgroundPinto-Alphandary, H., Balland, O., Laurent, M., Andremont, A., Puisieux, F., & Couvreur, P. (1994) · Pharmaceutical Research · doi:10.1023/a:1018985308984 · Cited by 53
Cited by
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173090 · Cited by 2,454
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Nanomaterial cytotoxicity is composition, size, and cell type dependent
Sohaebuddin, S. K., Thevenot, P. T., Baker, D., Eaton, J. W., & Tang, L. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-22 · Cited by 672
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B. L., & Edwards, D. A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 643
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Different Sizes
Yen, H., Hsu, S., & Tsai, C. (2009) · Small · doi:10.1002/smll.200900126 · Cited by 635
Lunov, O., Syrovets, T., Loos, C., Beil, J., Delacher, M., Tron, K., Nienhaus, G. U., Musyanovych, A., Mailänder, V., Landfester, K., et al. (2011) · ACS Nano · doi:10.1021/nn2000756 · Cited by 600
The effects of polymeric nanostructure shape on drug delivery
Venkataraman, S., Hedrick, J. L., Ong, Z. Y., Yang, C., Ee, P. L. R., Hammond, P. T., & Yang, Y. Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.016 · Cited by 510
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Tailoring Materials for Modulation of Macrophage Fate
Li, J., Jiang, X., Li, H., Gelinsky, M., & Gu, Z. (2021) · Advanced Materials · doi:10.1002/adma.202004172 · Cited by 403
Nanoparticle-based local antimicrobial drug delivery
Gao, W., Chen, Y., Zhang, Y., Zhang, Q., & Zhang, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.015 · Cited by 396
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 347
Recent advances in leishmaniasis treatment
Tiuman, T. S., Santos, A. O., Ueda-Nakamura, T., Filho, B. P. D., & Nakamura, C. V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.03.021 · Cited by 345
Mohamed, F., & van der Walle, C. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21082 · Cited by 299
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Amino-Functionalized Polystyrene Nanoparticles Activate the NLRP3 Inflammasome in Human Macrophages
Lunov, O., Syrovets, T., Loos, C., Nienhaus, G. U., Mailänder, V., Landfester, K., Rouis, M., & Simmet, T. (2011) · ACS Nano · doi:10.1021/nn203596e · Cited by 262
Non-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles
Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1634-1 · Cited by 107
Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages
Almouazen, E., Bourgeois, S., Boussaïd, A., Valot, P., Malleval, C., Fessi, H., Nataf, S., & Briançon, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.025 · Cited by 47
A feasible way to use carbon nanotubes to deliver drug molecules: transdermal application
Ilbasmis – Tamer, S., & Degim, I. T. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.696607 · Cited by 26
RTG-loaded nanomicelles (CS–VES–NAC) for oral anti-HIV drug delivery
Hu, L., Wu, J., Li, Z., Bu, M., Qiao, S., & Wang, H. (2016) · RSC Advances · doi:10.1039/c6ra09662j · Cited by 4
Metadata
- Authors
- Chellat, F., Merhi, Y., Moreau, A., & Yahia, L.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 26
- Issue
- 35
- Pages
- 7260-7275
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2039796373
- Cited by
- 237
- References
- 8
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.